Differential outcomes after sirolimus-eluting stent implantation: Comparing on-label versus off-label patients in the 'real world'

Coronary Artery Disease

Volumn 19, Issue 2, 2008, Pages 111-115

  Jeremias, Allen ^a,d   Ruisi, Christopher P ^b   Kirtane, Ajay J ^b   Lee, Tobias ^b   Sylvia, Brett ^b   Pinto, Duane S ^b   Ho, Kalon K L ^b   Cutlip, Donald E ^b   Carrozza Jr , Joseph P ^b   Cohen, David J ^c  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^d STONY BROOK UNIVERSITY   (United States)

Author keywords

Coronary artery disease; Drug eluting stents; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART EJECTION FRACTION; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; REVASCULARIZATION; SIDE EFFECT; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS; CORONARY RESTENOSIS; CORONARY STENOSIS; DEATH; DRUG-ELUTING STENTS; ELIGIBILITY DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; REPRODUCIBILITY OF RESULTS; SIROLIMUS;

EID: 39849094155     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3282f34220     Document Type: Article

References (9)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773-1780.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349:1315-1323.
3. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, Breithardt G, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362:1093- 1099.
4. Ardissino D, Cavallini C, Bramucci E, Indolfi C, Marzocchi A, Manari A, et al. Sirolimus-eluting versus uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA 2004; 292:2727-2734.
5. Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis C, Hoye A, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the 'real world': the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004; 109:190-195.
6. Marzocchi A, Piovaccari G, Manari A, Aurier E, Benassi A, Saia F, et al. Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events. Am J Cardiol 2005; 95: 1409-1414.
7. Jeremias A, Sylvia B, Bridges J, Kertane AJ, Bigelow B, Pinto DS, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 2004; 109:1930-1932.
8. Cutlip DE, Chauhan MS, Baim DS, Ho KKL, Popma JJ, Carrozza JP, et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol 2002; 40:2082-2089.
9. Singh M, Williams BA, Gersh BJ, McClelland RL, Ho KKL, Willerson JT, et al. Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the prevention of restenosis with tranilast and its outcomes (PRESTO) Trial. J Am Coll Cardiol 2006; 47:34-39.